Shares of AbbVie Inc (NYSE:ABBV) ended Wednesday session at $63.34 with 5.89 million shares getting traded. Post opening the session at $63.41, the shares hit an intraday low of $63.06 and an intraday high of $63.96 and the price vacillated in this range throughout the day. The company has a market cap of $101.96 billion and the numbers of outstanding shares have been calculated to be 1.63 billion shares.
On Sept. 9, 2016 The board of directors of AbbVie Inc. (ABBV) declared a quarterly cash dividend of $0.57 per share.
The cash dividend is payable Nov. 15, 2016 to stockholders of record at the close of business on Oct. 14, 2016.
Since the company’s inception in 2013, AbbVie has increased its dividend by more than 42 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.
Shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) ended Wednesday session in green amid volatile trading. The shares closed up +0.41 points or 0.80% at $51.95 with 5.63 million shares getting traded. Post opening the session at $51.81, the shares hit an intraday low of $51.62 and an intraday high of $52.66 and the price vacillated in this range throughout the day. The company has a market cap of $52.77 billion and the numbers of outstanding shares have been calculated to be 1.01 billion shares.
On September 7, 2016 Teva UK Ltd. released results of a UK survey showing that people over the age of 55 feel in high control of their health and that over 55s are more likely than other age groups in the UK to feel it’s their responsibility to influence their own health. The research, involving 1000 participants in the UK, also indicated UK baby boomers believe it’s important to take care of one’s own health to avoid major health-related expenses in the future.
But the study also revealed a generational “digital divide” in attitudes toward managing one’s health. Research found that people over 55 in the UK are least likely of any age group to seek advice on how to take better control of their health. They’re also least likely to search for health information online, with only a third saying they find health information online dependable. The UK survey also found that less than half of over 55s surveyed said they actively seek new information about their health – despite over 80% saying it’s their responsibility to influence their own health.
Teva UK has published these findings to coincide with the start of NHS England’s Health & Care Innovation Expo 2016, which opened in Manchester. Teva is serving as NHS England’s Digital Zone partner at this year’s Expo, with the aim of sharing experiences, examining best practices, and understanding drivers and barriers to adopting digital technology in healthcare.